Literature DB >> 14645463

Rating scales for neurologists.

J Hobart1.   

Abstract

Mesh：

Year:  2003        PMID： 14645463      PMCID： PMC1765638          DOI： 10.1136/jnnp.74.suppl_4.iv22

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

Authors:  J A Cohen; G R Cutter; J S Fischer; A D Goodman; F R Heidenreich; A J Jak; J E Kniker; M F Kooijmans; J M Lull; A W Sandrock; J H Simon; N A Simonian; J N Whitaker
Journal:  Arch Neurol       Date:  2001-06

2.  Observations are always ordinal; measurements, however, must be interval.

Authors:  B D Wright; J M Linacre
Journal:  Arch Phys Med Rehabil       Date:  1989-11       Impact factor: 3.966

3.  Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).

Authors:  J C Hobart; A Riazi; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

4.  The measurement of vision disability.

Authors:  Robert W Massof
Journal:  Optom Vis Sci       Date:  2002-08       Impact factor: 1.973
  4 in total
  20 in total

1.  The 39-Item Parkinson's Disease Questionnaire (PDQ-39): Is it a Unidimensional Construct?

Authors:  Peter Hagell; Maria H Nilsson
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Self-reported health in people with Parkinson's disease left untreated at diagnosis.

Authors:  Peter Hagell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

3.  Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis.

Authors:  J A McGrane; P N Butow; M Sze; M Eisenbruch; D Goldstein; M T King
Journal:  Qual Life Res       Date:  2014-05-24       Impact factor: 4.147

4.  Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.

Authors:  Melissa R Mandarakas; Manoj P Menezes; Kristy J Rose; Rosemary Shy; Kate Eichinger; Maria Foscan; Timothy Estilow; Rachel Kennedy; Karen Herbert; Paula Bray; Kathryn Refshauge; Monique M Ryan; Eppie M Yiu; Michelle Farrar; Hugo Sampaio; Isabella Moroni; Emanuela Pagliano; Davide Pareyson; Sabrina W Yum; David N Herrmann; Gyula Acsadi; Michael E Shy; Joshua Burns; Oranee Sanmaneechai
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

Review 5.  Performance and Capacity Measurement of the Lower Extremities in Multiple Sclerosis -How to Approach?

Authors:  Sıla Usar İncirli; Özlem Taşkapilioğlu
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

6.  The Pain and Sleep Questionnaire three-item index (PSQ-3): a reliable and valid measure of the impact of pain on sleep in chronic nonmalignant pain of various etiologies.

Authors:  Lindsay Ayearst; Zoltan Harsanyi; Kenneth J Michalko
Journal:  Pain Res Manag       Date:  2012 Jul-Aug       Impact factor: 3.037

7.  Validation of a Chinese version of the Frenchay Activities Index in patients with traumatic limb injury.

Authors:  Jen-Suh Chern; Mei-Hsiang Chen; Ya-Chen Lee; Sheng-Shiung Chen; Li-Fong Lin; Wen-Hsuan Hou; Ching-Lin Hsieh
Journal:  J Occup Rehabil       Date:  2014-09

8.  Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force.

Authors:  Marc K Walton; John H Powers; Jeremy Hobart; Donald Patrick; Patrick Marquis; Spiros Vamvakas; Maria Isaac; Elizabeth Molsen; Stefan Cano; Laurie B Burke
Journal:  Value Health       Date:  2015-08-24       Impact factor: 5.725

9.  The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.

Authors:  Peter Hagell; Carita Nygren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

10.  Can and should neurologists screen their patients for depression? Yes, and….

Authors:  John P Ney; Saty Satya-Murti
Journal:  Neurol Clin Pract       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.